Lack of any Association between Blood Groups and Lung Cancer, Independent of Histology

Oguz, Arzu; Unal, Dilek; Tasdemir, Arzu; Karahan, Samet; Aykas, Fatma; Mutlu, Hasan; Cihan, Yasemin Benderli; Kanbay, Mehmet

추천

검색

자료유형: 학술저널

저자정보: Oguz, Arzu (Medical Oncology Clinic, Kayseri Education and Research Hospital) Unal, Dilek (Radiation Oncology Clinic, Kayseri Education and Research Hospital) Tasdemir, Arzu (Pathology Clinic, Kayseri Education and Research Hospital) Karahan, Samet (Internal Medicine Clinic, Kayseri Education and Research Hospital) Aykas, Fatma (Internal Medicine Clinic, Kayseri Education and Research Hospital) Mutlu, Hasan (Medical Oncology Clinic, Acibadem Hospital) Cihan, Yasemin Benderli (Radiation Oncology Clinic, Acibadem Hospital) Kanbay, Mehmet (Nephrology Clinic, Istanbul Medeniyet University)

저널정보: 아시아태평양암예방학회 Asian Pacific journal of cancer prevention : APJCP Asian Pacific journal of cancer prevention : APJCP 제14권 제1호

발행연도: 2013.1

수록면: 453 - 456 (4page)

이용수

📌

연구주제

📖

연구배경

🔬

연구방법

🏆

연구결과

초록· 키워드

오류제보하기

Introduction: Lung cancer, the leading cause of cancer deaths, is divided into 2 main classes based on its biology, therapy and prognosis: non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Many cases are at an advanced stage at diagnosis, which is a major obstacle to improving outcomes. It is important to define the high risk group patients for early diagnosis and chance of cure. Blood group antigens are chemical components on erythrocyte membranes but they are also expressed on a variety of epithelial cells. Links between ABO blood groups with benign or malignant diseases, such as gastric and pancreas cancers, have been observed for a long time. In this study, we aimed to investigate any possible relationship between lung cancer histological subtypes and ABO-Rh blood groups. Materials and Methods: The files of 307 pathologically confirmed lung cancer patients were reviewed retrospectively. Cases with a serologically determined blood group and Rh factor were included and those with a history of another primary cancer were excluded, leaving a total of 221. The distribution of blood groups of the lung cancer patients were compared with the distribution of blood groups of healthy donors admitted to the Turkish Red Crescent Blood Service in our city in the year 2012. Results: There was no significant difference between patients with lung cancer of either type and the control group in terms of distribution of ABO blood groups and Rh factor (p: 0.073). There was also no relationship with non small cell cancer histological subtypes. Conclusions: In this study, we found no relationship between the ABO-Rhesus blood groups and NSCLC and SCLC groups. To our knowledge this is the first analysis of ABO blood groups in SCLC patients.

#Lung cancer #ABO blood groups #Rh factor #SCLC #NSCLC #Turkey

참고문헌 (0)

참고문헌 신청

참고문헌이 DBpia에서 서비스 중이라면, [참고문헌 신청]을 통해 등록해보세요